Dr. Lal Path Labs Share Price

Q: What is Dr. Lal Path Labs share price today?

Dr. Lal Path Labs share price is ₹1,639.10 as on 03 Jul, 2026, 15:29 IST.

Q: How has the Dr. Lal Path Labs share price performed in the past?

In the last 1 year, Dr. Lal Path Labs delivered a return of 19.40%. The Dr. Lal Path Labs share price hit a high of ₹1,803.00 and low of ₹1,272.60.

Q: How much is the Mutual Fund shareholding in Dr. Lal Path Labs shares?

The Mutual Fund Shareholding in Dr. Lal Path Labs was 18.62% at the end of Mar 2026.

Q: What is the the 52-week high and low of Dr. Lal Path Labs shares ?

The 52-week high and low of Dr. Lal Path Labs share is ₹1,803.00 and ₹1,272.60 as of 03 Jul, 2026.

Q: What is the market cap of Dr. Lal Path Labs?

The market capitalisation of Dr. Lal Path Labs is ₹27,697.10 Crores as on 03 Jul, 2026.

Q: What are the stock symbols of Dr. Lal Path Labs?

The stock symbol of Dr. Lal Path Labs is LALPATHLAB on the NSE, 539524 on the BSE, and the ISIN is INE600L01024.

Q: What was yesterday's closing price of Dr. Lal Path Labs shares ?

Dr. Lal Path Labs shares closed yesterday at ₹1,650.30 on NSE & ₹1,652.20 on BSE

Q: How to buy Dr. Lal Path Labs shares?

To buy Dr. Lal Path Labs shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.

Q: Can I buy Dr. Lal Path Labs shares on Holidays?

No, shares of Dr. Lal Path Labs or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Dr. Lal Path Labs shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

Q: What is the PE and PB ratio of Dr. Lal Path Labs?

The PE and PB ratio of Dr. Lal Path Labs is 54.33 and 11.04 respectively, as on 03 Jul, 2026, 15:29 IST.

NSE: LALPATHLAB

Healthcare Services

₹ 1,639.10

-₹11.20 (-0.68%)

Last updated 03 Jul, 2026, 15:29 IST

Dr. Lal Path Labs Share Price Today

As of 5 Jul 2026, Dr. Lal Path Labs share price is ₹1,639.10. The stock opened at ₹1,655.00, compared to its previous close of ₹1,650.30. During today's trading session, Dr. Lal Path Labs share price moved in the range of ₹1,620.30 to ₹1,655.00, with an average price of ₹1,637.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,272.60 and a high of ₹1,803.00. On the performance front, Dr. Lal Path Labs share price has increased by 11.63% over the last six months and is up 19.40% on a year-on-year basis.

₹1,620.30

0.68% down today

₹1,655.00

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 28.80% QoQ

Latest Earning

Net Profit TrendUp by 44.64% QoQ

Latest Earning

Revenue TrendUp by 6.21% QoQ

Stock Performance

OutperformingBeat Nifty by 2.77 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 16.73%

Shareholding Pattern

FIIFII decreased stake by 15.31%

Dr. Lal Path Labs Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,77,641+₹77,641 (+15.53%)

3 Year

₹7,07,402+₹2,07,402 (+41.48%)

5 Year

₹4,62,743-₹37,257 (-7.45%)

Open

₹1,655.00

High

₹1,655.00

Low

₹1,620.30

Prev. close

₹1,650.30

₹1,316.60₹1,974.80

Circuit Low

Circuit High

₹1,272.60₹1,803.00

52-Week Low

52-Week High

Circuit

₹1,316.60

₹1,974.80

52-week

₹1,272.60

₹1,803.00

Dr. Lal Path Labs Shareholder Returns

Dr. Lal Path Labs Share Price History

Mkt Cap Cr

27,697.10

P/E

54.33

P/B

11.04

ROE

20.13%

D/E

0.07

ROCE

25.56%

Div. Yield

1.56%

EPS(TTM)

30.45

Turnover

1.01

EV/EBITDA

31.04

Net Margin

19.20%

Op. Margin

31.59%

ROA

16.20%

Quick Ratio

3.35

Curr. Ratio

2.70

Mkt Cap Cr

27,697.10

P/E

54.33

P/B

11.04

ROE

20.13%

D/E

0.07

ROCE

25.56%

Div. Yield

1.56%

EPS(TTM)

30.45

Turnover

1.01

EV/EBITDA

31.04

Net Margin

19.20%

Op. Margin

31.59%

ROA

16.20%

Quick Ratio

3.35

Curr. Ratio

2.70

Based on fundamentals, this stock's

Performance

Excellent

Dr Lal Pathlabs outperforming all market indices

Valuation

Fairly Valued

Dr Lal Pathlabs appears to be fairly valued compared to its peers

Earnings

Excellent

Dr Lal Pathlabs revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,25,057.00	62.45	13.20	20.48%	0.32	17.27%	692.92	0.23%	0.70	103.81
Max Healthcare	1,09,728.00	76.08	10.21	13.42%	0.09	12.97%	91.86	0.18%	0.28	7.37
Fortis Healthcare	73,604.60	69.15	7.44	10.53%	0.23	12.56%	122.24	0.10%	0.16	3.05
Aster DM Healthcare	40,962.60	95.95	9.69	8.48%	0.31	10.10%	83.23	0.38%	0.46	5.20
Narayana Hrudayalaya	40,570.70	50.34	8.94	17.76%	0.76	11.42%	127.10	0.23%	0.85	24.77
Global Health	36,176.70	65.28	9.13	14.05%	0.06	15.26%	149.24	0.04%	0.77	18.46
KRISHNA INST OF MED SCI L	35,097.80	145.08	9.37	10.74%	0.63	7.99%	93.54	0.00%	0.46	6.52
Syngene International	17,755.40	56.03	3.67	7.76%	0.04	9.67%	116.55	0.28%	0.67	7.58
Poly Medicure	17,614.20	54.92	5.67	10.37%	0.08	12.71%	301.18	0.20%	0.53	33.15
DR AGARWALS HEALTH CARE L	15,099.50	89.88	7.45	6.58%	0.34	9.75%	62.82	0.00%	0.49	1.25

Dr. Lal Path Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹2,461.40	₹2,226.64	₹2,016.88	₹2,087.41
Other Income	₹93.43	₹69.17	₹41.72	₹52.55
Total Revenue	₹2,554.83	₹2,295.81	₹2,058.60	₹2,139.95
Total Expenses	₹1,930.03	₹1,790.36	₹1,714.77	₹1,664.97
Profit Before Tax	₹624.80	₹505.45	₹343.83	₹474.98
Tax	₹132.55	₹143.16	₹102.75	₹124.69
Profit After Tax	₹492.25	₹362.29	₹241.08	₹350.29
EPS - Basic	₹58.48	₹43.05	₹28.82	₹41.70
EPS - Diluted	₹58.40	₹42.98	₹28.74	₹41.57

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹492.25	₹362.29	₹241.08	₹350.29
Income before WC changes	₹726.77	₹631.63	₹526.99	₹593.43
Change in Assets	-₹17.61	-₹12.84	₹25.09	-₹45.86
Change in Liabilities	₹23.62	₹48.58	₹10.38	₹29.15
Change in WC	₹6.02	₹35.74	₹35.48	-₹16.71
Cash flow from Operations	₹568.89	₹535.33	₹456.03	₹446.69
Cash flow from Investing	-₹303.16	-₹24.27	-₹287.31	-₹449.25
Cash flow from Financing	-₹334.03	-₹413.86	-₹283.18	₹136.45
Total Cash Flow	-₹68.31	₹97.20	-₹114.46	₹133.90
Cash (Start of the year)	₹360.93	₹263.73	₹378.20	₹244.30
Cash (End of the year)	₹292.63	₹360.93	₹263.73	₹378.20

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,353.28	₹1,329.27	₹1,412.48	₹1,478.07
Current Assets	₹1,363.51	₹1,126.70	₹973.09	₹875.15
Total Assets	₹2,716.79	₹2,455.96	₹2,385.56	₹2,353.22
Current Liabilities	₹402.35	₹465.19	₹469.75	₹499.99
Net Current Asset	₹961.16	₹661.51	₹503.33	₹375.16
Non-Current Liabilities	₹107.96	₹105.41	₹216.26	₹309.70
Equity Capital	₹2,206.48	₹1,885.36	₹1,699.55	₹1,543.54
Total Equity & Liabilities	₹2,716.79	₹2,455.96	₹2,385.56	₹2,353.22

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹2,351.62	₹2,125.06	₹1,769.03	₹1,878.79
Other Income	₹111.52	₹66.30	₹46.60	₹53.10
Total Revenue	₹2,463.14	₹2,191.37	₹1,815.63	₹1,931.89
Total Expenses	₹1,841.86	₹1,708.84	₹1,424.80	₹1,470.90
Profit Before Tax	₹621.28	₹482.53	₹390.83	₹460.99
Tax	₹124.02	₹135.80	₹98.47	₹115.74
Profit After Tax	₹497.26	₹346.73	₹292.36	₹345.25
EPS - Basic	₹59.70	₹41.72	₹35.28	₹41.75
EPS - Diluted	₹59.61	₹41.66	₹35.17	₹41.63

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹497.26	₹346.73	₹292.36	₹345.25
Income before WC changes	₹696.07	₹602.75	₹487.14	₹548.80
Change in Assets	-₹24.29	-₹18.35	₹19.61	-₹8.70
Change in Liabilities	₹22.85	₹48.02	₹19.91	₹3.15
Change in WC	-₹1.44	₹29.67	₹39.52	-₹5.55
Cash flow from Operations	₹540.00	₹504.60	₹427.53	₹425.73
Cash flow from Investing	-₹293.00	₹1.17	-₹288.47	-₹448.53
Cash flow from Financing	-₹324.75	-₹410.53	-₹270.05	₹141.24
Total Cash Flow	-₹77.75	₹95.24	-₹130.99	₹118.43
Cash (Start of the year)	₹344.34	₹249.10	₹351.31	₹232.87
Cash (End of the year)	₹266.60	₹344.34	₹220.32	₹351.31

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,343.67	₹1,312.77	₹1,510.00	₹1,511.47
Current Assets	₹1,277.28	₹1,036.39	₹810.17	₹699.31
Total Assets	₹2,620.95	₹2,349.16	₹2,320.17	₹2,210.78
Current Liabilities	₹388.44	₹450.47	₹432.16	₹451.04
Net Current Asset	₹888.85	₹585.92	₹378.01	₹248.28
Non-Current Liabilities	₹98.28	₹97.97	₹198.15	₹287.63
Equity Capital	₹2,134.23	₹1,800.72	₹1,689.86	₹1,472.12
Total Equity & Liabilities	₹2,620.95	₹2,349.16	₹2,320.17	₹2,210.78

* All values are in INR Crore

Qty

Bid

1645.7

Ask

Qty

Bid Total: 20

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Neutral

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

54.64

Neutral

ATR (14)

57.04

Neutral

STOCH(9,6)

40.23

Neutral

STOCH RSI (14)

26.68

Neutral

ADX(9)

22.2

Bearish

UO(9)

44.53

Neutral

ROC(12)

0.23

Bullish

WillR(14)

-70.29

Neutral

Period

Simple value

Exponential vaue

1642.46

1646.41

10D

1653.87

1645.41

20D

1626.69

1632.91

50D

1587.94

1583.26

100D

1485.8

1534.58

About Dr. Lal Path Labs

ISIN

INE600L01024

Sector Market Cap

₹ 27,697.1 Cr

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

Dr. Lal Path Labs Financial Highlights

Revenue: Dr. Lal Path Labs reported revenue of ₹2,864.20 crore in FY26 vs ₹2,554.80 crore in FY25. It showed an increase of 12.11% on a yearly basis.
Operating Profit: Dr. Lal Path Labs reported an operating profit of ₹669.10 crore in FY26 vs ₹624.70 crore in FY25. It showed an increase of 7.11% on a year-on-year basis.
Net Profit: Dr. Lal Path Labs reported a net profit of ₹509.80 crore in FY26 vs ₹492.20 crore in FY25. It showed an increase of 3.58% on a yearly basis.

Dr. Lal Path Labs Quarterly Result Highlights

Dr. Lal Path Labs reported revenue of ₹726.70 crore in Mar 2026, compared with ₹684.20 crore in Dec 2025, representing an increase of 6.21% on a quarter-on-quarter (QoQ) basis.
Dr. Lal Path Labs reported an operating profit of ₹160.10 crore in Mar 2026, compared with ₹124.30 crore in Dec 2025, representing an increase of 28.80% on a quarter-on-quarter (QoQ) basis.
Dr. Lal Path Labs reported a profit of ₹132.20 crore in Mar 2026, compared with ₹91.40 crore in Dec 2025, reflecting an increase of 44.64% on a QoQ basis.
The earnings per share (EPS) of Dr. Lal Path Labs stood at ₹58.48 during Mar 2026.